Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview.
Priyabrata Pattanayak, Pritishova Behera, Debajyoti Das...
https://pubmed.ncbi.nlm.nih.gov/22228948/Actively Recruiting
Led by Mahidol University · Updated on 2026-03-24
27
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating whether holy basil extract can reduce gastric inflammation and improve symptoms in adults with dyspepsia, a condition causing chronic upper abdominal discomfort without structural disease. The study aims to answer if holy basil can decrease gastric mucosal inflammation and improve symptoms, endoscopic findings, gastric pH levels, duodenal eosinophil counts, and systemic inflammation measured by serum IL-6. Participants will take 300 mg of holy basil extract orally once daily for 28 days. Before and after treatment, they will undergo upper endoscopy with biopsy and 24-hour intragastric pH monitoring. The study includes baseline and end-of-treatment symptom questionnaires and diaries. Weekly monitoring during treatment will track symptoms, adverse events, and medication compliance. Throughout the study, participants will provide blood samples to measure inflammatory markers and be monitored for safety. The main outcome is the change in gastric mucosal inflammation seen in biopsy samples. Secondary outcomes include changes in dyspeptic and reflux symptoms, gastric mucosal appearance, duodenal eosinophil counts, intragastric pH, esophageal acid exposure, serum IL-6 levels, and adverse events. Participation lasts for at least 28 days of treatment with assessments before and after this period.
CONDITIONS
Holy Basil in The Treatment of Dyspepsia
M
Monthira Maneerattanaporn, MD
P
Pubet Weeranawin, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mahidol University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 28 days
Participants take one 300 mg capsule of holy basil extract daily for 28 days to evaluate its effect on dyspepsia symptoms and gastric inflammation.
Weekly visits for symptom review, adverse event monitoring, and medication compliance
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Priyabrata Pattanayak, Pritishova Behera, Debajyoti Das...
https://pubmed.ncbi.nlm.nih.gov/22228948/Lucas Wauters, Nicholas J Talley, Marjorie M Walker...
https://pubmed.ncbi.nlm.nih.gov/31784469/Negar Jamshidi, Marc M Cohen
https://pubmed.ncbi.nlm.nih.gov/28400848/Poonam Dharmani, Vijay Kumar Kuchibhotla, Rakesh Maurya...
https://pubmed.ncbi.nlm.nih.gov/15234753/Alexander C Ford, Paul Moayyedi, Christopher J Black...
https://pubmed.ncbi.nlm.nih.gov/32936964/Mahidol University
Lead Sponsor